Summary

The research team projects that the Third-Party Drug Testing Administration service market size will grow from XXX in 2025 to XXX by 2030, at an estimated CAGR of XX. The base year considered for the study is 2024, and the market size is projected from 2025 to 2030.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
Lobdock
Info Cubic
Procom Testing
Midway
National Drug Screening
CO-OP Drug Testing
ADVANTAGECARE
CannAmm
Medway
AMDT
WorkPlace Health
Global Verification Network
Mobile Medical Corporation
DRUG TESTING CORPORATION
Origin

By Type
Pre-Employment Drug Testing
Reasonable Suspicion Drug Testing
Random Drug Testing
Return-to-Duty Drug Testing
Post-Accident Drug Testing
Others

By Application
SMEs
Large Enterprise

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Third-Party Drug Testing Administration service 2019-2024, and development forecast 2025-2030 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2019-2024 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2025-2030. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Third-Party Drug Testing Administration service Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Third-Party Drug Testing Administration service Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Third-Party Drug Testing Administration service market in 2024. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Third-Party Drug Testing Administration service Revenue
1.4 Market Analysis by Type
1.4.1 Global Third-Party Drug Testing Administration service Market Size Growth Rate by Type: 2025 VS 2030
1.4.2 Pre-Employment Drug Testing
1.4.3 Reasonable Suspicion Drug Testing
1.4.4 Random Drug Testing
1.4.5 Return-to-Duty Drug Testing
1.4.6 Post-Accident Drug Testing
1.4.7 Others
1.5 Market by Application
1.5.1 Global Third-Party Drug Testing Administration service Market Share by Application: 2025-2030
1.5.2 SMEs
1.5.3 Large Enterprise
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Third-Party Drug Testing Administration service Market
1.8.1 Global Third-Party Drug Testing Administration service Market Status and Outlook (2019-2030)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
1.9 Global Market Growth Prospects
1.9.1 Global Third-Party Drug Testing Administration service Revenue Estimates and Forecasts (2019-2030)
1.9.2 Global Third-Party Drug Testing Administration service Production Capacity Estimates and Forecasts (2019-2030)
1.9.3 Global Third-Party Drug Testing Administration service Production Estimates and Forecasts (2019-2030)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material
2.2 Manufacturing Cost Structure Analysis of Third-Party Drug Testing Administration service
2.3 Manufacturing Process Analysis of Third-Party Drug Testing Administration service
2.4 Industry Chain Structure of Third-Party Drug Testing Administration service
3 Development and Manufacturing Plants Analysis of Third-Party Drug Testing Administration service
3.1 Top Manufacturers Headquarters, Rank by Third-Party Drug Testing Administration service Production
3.2 Global Third-Party Drug Testing Administration service Manufacturing Plants Distribution and Commercial Production Date
4 Market Competition by Manufacturers
4.1 Global Third-Party Drug Testing Administration service Production Capacity Market Share by Manufacturers (2019-2024)
4.2 Global Third-Party Drug Testing Administration service Revenue Market Share by Manufacturers (2019-2024)
4.3 Global Third-Party Drug Testing Administration service Average Price by Manufacturers (2019-2024)
4.4 Manufacturers Third-Party Drug Testing Administration service Production Sites, Area Served, Product Type
5 Third-Party Drug Testing Administration service Regional Market Analysis
5.1 Third-Party Drug Testing Administration service Production by Regions
5.1.1 Global Third-Party Drug Testing Administration service Production by Regions (2019-2024)
5.1.2 Global Third-Party Drug Testing Administration service Revenue by Regions
5.2 Third-Party Drug Testing Administration service Consumption by Regions
5.3 North America Third-Party Drug Testing Administration service Market Analysis
5.3.1 North America Third-Party Drug Testing Administration service Production
5.3.2 North America Third-Party Drug Testing Administration service Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Third-Party Drug Testing Administration service Import and Export
5.4 East Asia Third-Party Drug Testing Administration service Market Analysis
5.4.1 East Asia Third-Party Drug Testing Administration service Production
5.4.2 East Asia Third-Party Drug Testing Administration service Revenue
5.4.3 Key Manufacturers in East Asia
5.4.4 East Asia Third-Party Drug Testing Administration service Import & Export
5.5 Europe Third-Party Drug Testing Administration service Market Analysis
5.5.1 Europe Third-Party Drug Testing Administration service Production
5.5.2 Europe Third-Party Drug Testing Administration service Revenue
5.5.3 Key Manufacturers in Europe
5.5.4 Europe Third-Party Drug Testing Administration service Import & Export
5.6 South Asia Third-Party Drug Testing Administration service Market Analysis
5.6.1 South Asia Third-Party Drug Testing Administration service Production
5.6.2 South Asia Third-Party Drug Testing Administration service Revenue
5.6.3 Key Manufacturers in South Asia
5.6.4 South Asia Third-Party Drug Testing Administration service Import & Export
5.7 Southeast Asia Third-Party Drug Testing Administration service Market Analysis
5.7.1 Southeast Asia Third-Party Drug Testing Administration service Production
5.7.2 Southeast Asia Third-Party Drug Testing Administration service Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Third-Party Drug Testing Administration service Import & Export
5.8 Middle East Third-Party Drug Testing Administration service Market Analysis
5.8.1 Middle East Third-Party Drug Testing Administration service Production
5.8.2 Middle East Third-Party Drug Testing Administration service Revenue
5.8.3 Key Manufacturers in Middle East
5.8.4 Middle East Third-Party Drug Testing Administration service Import & Export
5.9 Africa Third-Party Drug Testing Administration service Market Analysis
5.9.1 Africa Third-Party Drug Testing Administration service Production
5.9.2 Africa Third-Party Drug Testing Administration service Revenue
5.9.3 Key Manufacturers in Africa
5.9.4 Africa Third-Party Drug Testing Administration service Import & Export
5.10 Oceania Third-Party Drug Testing Administration service Market Analysis
5.10.1 Oceania Third-Party Drug Testing Administration service Production
5.10.2 Oceania Third-Party Drug Testing Administration service Revenue
5.10.3 Key Manufacturers in Oceania
5.10.4 Oceania Third-Party Drug Testing Administration service Import & Export
5.11 South America Third-Party Drug Testing Administration service Market Analysis
5.11.1 South America Third-Party Drug Testing Administration service Production
5.11.2 South America Third-Party Drug Testing Administration service Revenue
5.11.3 Key Manufacturers in South America
5.11.4 South America Third-Party Drug Testing Administration service Import & Export
6 Third-Party Drug Testing Administration service Sales Market by Type (2019-2030)
6.1 Global Third-Party Drug Testing Administration service Historic Market Size by Type (2019-2024)
6.2 Global Third-Party Drug Testing Administration service Forecasted Market Size by Type (2025-2030)
7 Third-Party Drug Testing Administration service Consumption Market by Application(2019-2030)
7.1 Global Third-Party Drug Testing Administration service Historic Market Size by Application (2019-2024)
7.2 Global Third-Party Drug Testing Administration service Forecasted Market Size by Application (2025-2030)
8 Company Profiles and Key Figures in Third-Party Drug Testing Administration service Business
8.1 Lobdock
8.1.1 Lobdock Company Profile
8.1.2 Lobdock Third-Party Drug Testing Administration service Product Specification
8.1.3 Lobdock Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2 Info Cubic
8.2.1 Info Cubic Company Profile
8.2.2 Info Cubic Third-Party Drug Testing Administration service Product Specification
8.2.3 Info Cubic Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3 Procom Testing
8.3.1 Procom Testing Company Profile
8.3.2 Procom Testing Third-Party Drug Testing Administration service Product Specification
8.3.3 Procom Testing Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4 Midway
8.4.1 Midway Company Profile
8.4.2 Midway Third-Party Drug Testing Administration service Product Specification
8.4.3 Midway Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5 National Drug Screening
8.5.1 National Drug Screening Company Profile
8.5.2 National Drug Screening Third-Party Drug Testing Administration service Product Specification
8.5.3 National Drug Screening Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6 CO-OP Drug Testing
8.6.1 CO-OP Drug Testing Company Profile
8.6.2 CO-OP Drug Testing Third-Party Drug Testing Administration service Product Specification
8.6.3 CO-OP Drug Testing Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7 ADVANTAGECARE
8.7.1 ADVANTAGECARE Company Profile
8.7.2 ADVANTAGECARE Third-Party Drug Testing Administration service Product Specification
8.7.3 ADVANTAGECARE Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8 CannAmm
8.8.1 CannAmm Company Profile
8.8.2 CannAmm Third-Party Drug Testing Administration service Product Specification
8.8.3 CannAmm Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9 Medway
8.9.1 Medway Company Profile
8.9.2 Medway Third-Party Drug Testing Administration service Product Specification
8.9.3 Medway Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10 AMDT
8.10.1 AMDT Company Profile
8.10.2 AMDT Third-Party Drug Testing Administration service Product Specification
8.10.3 AMDT Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.11 WorkPlace Health
8.11.1 WorkPlace Health Company Profile
8.11.2 WorkPlace Health Third-Party Drug Testing Administration service Product Specification
8.11.3 WorkPlace Health Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.12 Global Verification Network
8.12.1 Global Verification Network Company Profile
8.12.2 Global Verification Network Third-Party Drug Testing Administration service Product Specification
8.12.3 Global Verification Network Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.13 Mobile Medical Corporation
8.13.1 Mobile Medical Corporation Company Profile
8.13.2 Mobile Medical Corporation Third-Party Drug Testing Administration service Product Specification
8.13.3 Mobile Medical Corporation Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.14 DRUG TESTING CORPORATION
8.14.1 DRUG TESTING CORPORATION Company Profile
8.14.2 DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Product Specification
8.14.3 DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.15 Origin
8.15.1 Origin Company Profile
8.15.2 Origin Third-Party Drug Testing Administration service Product Specification
8.15.3 Origin Third-Party Drug Testing Administration service Production Capacity, Revenue, Price and Gross Margin (2019-2024)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Third-Party Drug Testing Administration service (2025-2030)
9.2 Global Forecasted Revenue of Third-Party Drug Testing Administration service (2025-2030)
9.3 Global Forecasted Price of Third-Party Drug Testing Administration service (2019-2030)
9.4 Global Forecasted Production of Third-Party Drug Testing Administration service by Region (2025-2030)
9.4.1 North America Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.2 East Asia Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.3 Europe Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.4 South Asia Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.5 Southeast Asia Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.6 Middle East Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.7 Africa Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.8 Oceania Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.9 South America Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.4.10 Rest of the World Third-Party Drug Testing Administration service Production, Revenue Forecast (2025-2030)
9.5 Forecast by Type and by Application (2025-2030)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2025-2030)
9.5.2 Global Forecasted Consumption of Third-Party Drug Testing Administration service by Application (2025-2030)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Third-Party Drug Testing Administration service by Country
10.2 East Asia Market Forecasted Consumption of Third-Party Drug Testing Administration service by Country
10.3 Europe Market Forecasted Consumption of Third-Party Drug Testing Administration service by Countriy
10.4 South Asia Forecasted Consumption of Third-Party Drug Testing Administration service by Country
10.5 Southeast Asia Forecasted Consumption of Third-Party Drug Testing Administration service by Country
10.6 Middle East Forecasted Consumption of Third-Party Drug Testing Administration service by Country
10.7 Africa Forecasted Consumption of Third-Party Drug Testing Administration service by Country
10.8 Oceania Forecasted Consumption of Third-Party Drug Testing Administration service by Country
10.9 South America Forecasted Consumption of Third-Party Drug Testing Administration service by Country
10.10 Rest of the world Forecasted Consumption of Third-Party Drug Testing Administration service by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
12 Market Dynamics
12.1 Market Trends
12.2 Opportunities and Drivers
12.3 Challenges
12.4 Porter's Five Forces Analysis
13 Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer